SpaceM - BioInnovation Institute

BIO STUDIO PROJECT

SpaceM

About the Bio Studio program

PRINCIPAL INVESTIGATOR
Theodore Alexandrov
Group Leader at EMBL

"Theodore Alexandrov has been a Group Leader at the European Molecular Biology Laboratory (EMBL) in Heidelberg and the head of the EMBL Metabolomics Core Facility since 2014. He has also been an Assistant Adjunct Professor at the Skaggs School of Pharmacy, University of California San Diego for almost six years."

Read more
ENTREPRENEUR IN RESIDENCE
Bo Wiinberg
Entrepreneur in Residence

"Bo Wiinberg is a Senior Biotech Advisor at Biobridge Partners and an Entrepreneur in Residence at BioInnovation Institute for the SpaceM and OmniTx projects. He has a decade of experience from Novo Nordisk, building and leading several units across the pharma value chain from discovery to commercialization. At Novo Nordisk, Bo has, among others, held positions of Director & Head of Haemophilia Biology, R&am..."

Read more

PROJECT FAQ

Interview with Bo Wiinberg

Why have you decided to join the SpaceM project as an Entrepreneur in Residence?

After I left Novo Nordisk, I was looking for an opportunity to use the learnings I had from those years, combined with building something new. Helping commercialize cutting-edge technology was a good fit. SpaceM’s technology can be applied across R&D for drug development in many ways. Our task is to mature the technology and identify the best opportunities for commercial implementation—a detailed understanding of how drug discovery and development works is a clear advantage in that process.

What is your role as an Entrepreneur in Residence?

My role is to recruit and lead the team at BII to develop the technology to a stage where we can get external investors interested in funding the commercialization of SpaceM. To succeed, this includes all aspects of project management, performance management, budgeting, and the development of clear business goals for the team. We are also in constant contact with potential customers or partners to better understand their needs and how we might address them as we develop the platform to ensure a versatile and flexible solution that caters to the industry’s unmet needs.

What attracted you to become a part of BII’s entrepreneurial community?

On a personal level, it was a natural next step for me, having had both a successful academic and industry career. BII bridges those two, and having experience from both parts gives me the expertise to help projects transition from academia to the commercial space. However, there are still many vital learnings from the process, so this is also a growth and learning opportunity for me.

In addition to the individual company creation projects, the ambitious overall BII mission includes increasing and professionalizing the Danish biotech community to make Denmark an even greater international hub for biotech startups. This is an exciting and compelling journey to be part of!

What are some of the biggest learnings from your career that you bring to your position as an Entrepreneur in Residence?

Experience establishing and developing efficient and empowered teams and driving projects towards a goal with a clear purpose. It might sound simple, but many factors must be aligned to be successful. There is no single formula, so having experience with what is needed when facing various complex challenges is invaluable.

What are some of your near-term plans in this role?

I focus on continuously developing the team and ensuring we stay on track to deliver on what we set out to do—the first year involved establishing the team and transferring the technology to BII. In year two, we will focus on pivoting toward the optimal market for launch based on a thorough analysis of the opportunity landscape, which we completed at the end of the first year.

How did previous experiences shape your approach to the role of Entrepreneur in Residence?

Being in a startup environment can sometimes feel tumultuous, forcing you to navigate several unexpected challenges that must be solved constantly. Thus, you can quickly feel forced into reactive instead of proactive mode. Since I have seen and tried quite a few things in my career, I am resilient to that pressure and can keep calm at the moment while also preparing for which challenges the project might face in the months and years ahead. I believe one of my tasks is setting the agenda for the next phase of SpaceM’s development journey.

About the Bio Studio program

Read more
    Pages: 123